🇺🇸 FDA
Patent

US 7514415

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

granted A61KA61K31/7088A61K38/00

Quick answer

US patent 7514415 (Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/7088, A61K38/00, A61K45/06, A61P